Down-regulation of mortalin exacerbates Aβ-mediated mitochondrial fragmentation and dysfunction

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Mitochondrial dynamics are vital for neuronal energy supply and function.
• Mitochondrial dysfunction is a hallmark of neurodegenerative diseases like Alzheimer disease (AD).
• The precise regulatory mechanisms governing mitochondrial dynamics remain incompletely understood.

Purpose of the Study:

• To identify novel regulatory proteins involved in mitochondrial dynamics.
• To investigate the role of mortalin in mitochondrial regulation and its potential link to Alzheimer disease.

Main Methods:

• Screening of a mitochondrial siRNA library to identify regulatory proteins.
• Genetic and chemical inhibition of mortalin.
• Assessment of mitochondrial morphology, cytotoxicity, and cell death.
• Analysis of mortalin expression in Alzheimer disease patients and a transgenic AD mouse model.

Main Results:

• Identification of mortalin as a potential regulator of mitochondrial dynamics.
• Inhibition of mortalin led to mitochondrial fragmentation and increased Aβ-mediated cytotoxicity and dysfunction.
• Mortalin expression was significantly decreased in Alzheimer disease patients and an AD mouse model.
• Overexpression of mortalin protected against Aβ-mediated mitochondrial fragmentation and cell death.

Conclusions:

• Down-regulation of mortalin exacerbates Aβ-mediated mitochondrial fragmentation and dysfunction in Alzheimer disease.
• Mortalin plays a protective role against Alzheimer disease-related mitochondrial pathology.